HKD 3.05
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -102.25 Million CNY | -129.95% |
2022 | 377.3 Million CNY | -0.95% |
2021 | 380.93 Million CNY | 49.19% |
2020 | 255.33 Million CNY | 827.39% |
2019 | -35.1 Million HKD | 40.02% |
2018 | -58.52 Million HKD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -68.34 Million HKD | 16.06% |
2024 Q2 | -67.76 Million HKD | 0.15% |
2023 Q2 | 26.3 Million HKD | -5.52% |
2023 Q3 | -80.96 Million HKD | -407.78% |
2023 FY | -112.99 Million CNY | -129.95% |
2023 Q4 | -83.04 Million HKD | -2.57% |
2023 Q1 | 27.84 Million HKD | -65.58% |
2022 Q3 | 78.85 Million HKD | -72.14% |
2022 FY | 377.3 Million CNY | -0.95% |
2022 Q4 | 80.88 Million HKD | 2.58% |
2022 Q2 | 283 Million HKD | 0.0% |
2021 FY | 380.93 Million CNY | 49.19% |
2020 FY | 255.33 Million CNY | 827.39% |
2019 FY | -35.1 Million HKD | 40.02% |
2018 FY | -58.52 Million HKD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Life Healthcare Group Limited | 15.81 Million HKD | 746.472% |
China Biotech Services Holdings Limited | -95.44 Million HKD | -7.137% |